Skip to main content
  • Submit
  • About
    • Editorial Board
    • PNAS Staff
    • FAQ
    • Accessibility Statement
    • Rights and Permissions
    • Site Map
  • Contact
  • Journal Club
  • Subscribe
    • Subscription Rates
    • Subscriptions FAQ
    • Open Access
    • Recommend PNAS to Your Librarian
  • Log in
  • My Cart

Main menu

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses
  • Submit
  • About
    • Editorial Board
    • PNAS Staff
    • FAQ
    • Accessibility Statement
    • Rights and Permissions
    • Site Map
  • Contact
  • Journal Club
  • Subscribe
    • Subscription Rates
    • Subscriptions FAQ
    • Open Access
    • Recommend PNAS to Your Librarian

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Home
Home

Advanced Search

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses

New Research In

Physical Sciences

Featured Portals

  • Physics
  • Chemistry
  • Sustainability Science

Articles by Topic

  • Applied Mathematics
  • Applied Physical Sciences
  • Astronomy
  • Computer Sciences
  • Earth, Atmospheric, and Planetary Sciences
  • Engineering
  • Environmental Sciences
  • Mathematics
  • Statistics

Social Sciences

Featured Portals

  • Anthropology
  • Sustainability Science

Articles by Topic

  • Economic Sciences
  • Environmental Sciences
  • Political Sciences
  • Psychological and Cognitive Sciences
  • Social Sciences

Biological Sciences

Featured Portals

  • Sustainability Science

Articles by Topic

  • Agricultural Sciences
  • Anthropology
  • Applied Biological Sciences
  • Biochemistry
  • Biophysics and Computational Biology
  • Cell Biology
  • Developmental Biology
  • Ecology
  • Environmental Sciences
  • Evolution
  • Genetics
  • Immunology and Inflammation
  • Medical Sciences
  • Microbiology
  • Neuroscience
  • Pharmacology
  • Physiology
  • Plant Biology
  • Population Biology
  • Psychological and Cognitive Sciences
  • Sustainability Science
  • Systems Biology
Research Article

Mitigation strategies for pandemic influenza in the United States

Timothy C. Germann, Kai Kadau, Ira M. Longini Jr., and Catherine A. Macken
PNAS April 11, 2006 103 (15) 5935-5940; https://doi.org/10.1073/pnas.0601266103
Timothy C. Germann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: tcg@lanl.gov
Kai Kadau
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ira M. Longini Jr.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine A. Macken
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  1. Communicated by G. Balakrish Nair, International Centre for Diarrhoeal Disease Research Bangladesh, Dhaka, Bangladesh, February 16, 2006 (received for review January 10, 2006)

Related Article

  • In This Issue
    - Apr 11, 2006
  • Article
  • Figures & SI
  • Info & Metrics
  • PDF
Loading

Article Figures & SI

Figures

  • Tables
  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Two simulated pandemic influenza outbreaks with R 0 = 1.9, initiated by the daily entry of a small number of infected individuals through 14 major international airports in the continental U.S. (beginning on day 0). The tract-level prevalence of symptomatic cases at any point in time is indicated on a logarithmic color scale, from 0.03% (green) to 3% (red) of the population. No mitigation strategies are used in the baseline simulation (Left), resulting in a 43.5% attack rate. (Right) A 60% TAP intervention begins at day 31, or 7 days after the pandemic alert. At day 99, the nationwide supply of 20 million antiviral courses is exhausted, leading to a nationwide pandemic.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Epidemic curves (note the logarithmic scale) demonstrating the effectiveness of several different mitigation strategies, as compared to the baseline scenario without any intervention, for different values of R 0. See Table 2 for details of each intervention. In the case of vaccination, results shown here are for a uniform coverage of the entire population with a single-dose regimen.

Tables

  • Figures
    • View popup
    Table 1.

    Characteristics of simulated pandemic influenza in the U.S. in the absence of interventions

    Basic reproductive number, R 0 1.61.92.12.4
    Rate of spread: 1,000th ill person* 14131211
        10,000th ill person* 29242219
        100,000th ill person* 48373429
        1,000,000th ill person* 70524639
    Peak of epidemic* 117857564
    Daily number of new cases at peak activity2.3 M4.5 M6.0 M7.9 M
    Number of days with >100,000 new cases86686052
    Cumulative number of ill persons92 M122 M136 M151 M
    • M, million.

    • ↵*Days after initial introduction.

    • View popup
    Table 2.

    Simulated mean number of ill people (cumulative incidence per 100) and for TAP, the number of antiviral courses required for various interventions and R 0

    InterventionR0 = 1.6R0 = 1.9R0 = 2.1R0 = 2.4
    Baseline (no intervention)32.643.548.553.7
    Unlimited TAP (no. of courses)* 0.06 (2.8 M)4.3 (182 M)12.2 (418 M)19.3 (530 M)
    Dynamic vaccination (one-dose regimen) † , ‡ 0.717.730.141.1
    Dynamic child-first vaccination † , ‡ 0.042.816.335.3
    Dynamic vaccination (two-dose regimen) ‡ , § 3.233.841.148.5
    Dynamic child-first vaccination ‡ , § 0.925.137.247.3
    School closure ¶ 1.029.337.946.4
    Local social distancing ¶ 25.139.244.650.3
    Travel restrictions during entire simulation ‖ 32.844.048.954.1
    Local social distancing and travel restictions ¶ , ‖ 19.639.344.750.5
    TAP,* school closure,** and social distancing** 0.02 (0.6 M)0.07 (1.6 M)0.14 (3.3 M)2.8 †† (20 M)
    Dynamic vaccination, † , ‡ social distancing,¶ travel restrictions,¶‖ and school closure**0.040.20.64.5
    TAP,* dynamic vaccination, † , ‡ social distancing, ¶ travel restrictions,¶‖ and school closure**0.02 (0.3 M)0.03 (0.7 M)0.06 (1.4 M)0.1 (3.0 M)
    Dynamic child-first vaccination, † , ‡ social distancing, ¶ s travel restrictions, ¶ , ‖ and school closure** 0.020.20.97.7
    • M, million.

    • ↵*60% TAP, 7 days after pandemic alert, antiviral supply of 20 M courses unless stated.

    • ↵ †10 million doses of a low-efficacy vaccine (single-dose regimen) per week.

    • ↵ ‡Intervention continues for 25 weeks, beginning such that the first individuals treated develop an immune response on the date of the first U.S. introduction.

    • ↵ §10 million doses of a high-efficacy vaccine (two-dose regimen) per week.

    • ↵ ¶Intervention starting 7 days after pandemic alert.

    • ↵ ‖Reduction in long-distance travel, to 10% of normal frequency.

    • ↵**Intervention starting 14 days after pandemic alert.

    • ↵ ††Exhausted the available supply of 20 M antiviral courses.

Data supplements

  • Germann et al. 10.1073/pnas.0601266103.

    Supporting Information

    Files in this Data Supplement:

    Supporting Text
    Supporting Figure 3
    Supporting Figure 4
    Supporting Figure 5
    Supporting Table 3
    Supporting Table 4
    Supporting Table 5
    Supporting Table 6
    Supporting Table 7
    Supporting Figure 6
    Supporting Figure 7
    Supporting Movie 1
    Supporting Movie 2
    Supporting Movie 3
    Supporting Movie 4
    Supporting Figure 8
    Supporting Figure 9
    Supporting Table 8
    Supporting Table 9
    Supporting Table 10
    Supporting Figure 10
    Supporting Figure 11





    Supporting Figure 3

    Fig. 3. (a) Example of the calculation of the daily probability that a susceptible individual (blue) will become infected, due to infectious people (red) in various contact groups. For clarity, only the four household members and infectious contacts are shown; in general, each person may potentially come into contact with as many as 4,000 persons each day (2,000 each at their daytime and nighttime community locations). (b) Modeled natural history of influenza. Newly infected people pass through an incubation stage lasting from 1 to 3 days, slightly longer than the latent period during which they are completely noninfectious. Following the incubation period, we assume that 67% of infected people develop clinical symptoms, while 33% are asymptomatic and only half as infectious (the same as during the last day of the incubation period). Antiviral treatment is assumed to reduce both the likelihood of developing symptoms if infected and the infectious period by 1 day. Antivirals and vaccines can both reduce the infectiousness and susceptibility of infected and uninfected people, respectively.





    Supporting Figure 4

    Fig. 4. Illness attack rate for the different age groups as a function of transmission probability for the model community. For transmission probabilities 0.1, 0.12, 0.15, 0.17, and 0.2, the total illness attack rates are 23%, 34%, 44.5%, 49%, and 54%, respectively. The values are given for an ensemble of 500 isolated communities, each with 12 initial randomly infected persons. There is a one-to-one correspondence between transmission probabilities and R0 values; the transmission probabilities used in the present study are indicated by arrows, together with the corresponding R0 values as calculated by the slope of the cumulative number of cases (see Table 7).





    Supporting Figure 5

    Fig. 5. (a) Distribution of census tract populations. (b) Distribution of the distance between tract centers in the U.S. tract-to-tract worker flow data. Travel distances 100 miles or less are assumed to be daily commutes between home and work, while longer distances are neglected.





    Supporting Figure 6

    Fig. 6. The basic reproductive number (R0) for pandemic influenza, calculated by introducing one random infected person into a fully susceptible population in which no other person is able to transmit infection. This is repeated for 128,000 stochastic realizations, and the number of secondary cases is counted for each realization. The frequency distribution is shown here, which produces the overall average, R0 = 1.77 for a transmission probability Ptrans = 0.12. As seen in Table 7, the estimated R0 is increased by 5–8% by taking into account an attack rate weighted index case or estimating R0 by the slope of the cumulative number of cases, respectively.





    Supporting Figure 7

    Fig. 7. (Upper) The reproductive number R as a function of time for different transmission probabilities for simulations of the whole nation seeded at the beginning with 8 infected persons per 10,000 daily international passengers at the 14 major hubs. The full lines are values based on the local slope, whereas the open circles are based on slope averages starting at day 30. The initial reproductive number is enhanced due to the fact that school-age children, who have a higher reproductive number, are hit earliest (see Table 7 and bottom panel). (Lower) The age-specific cumulative attack rate normalized by the overall cumulative attack rate during the course of an epidemic in an ensemble of 500 isolated communities initially seeded with 12 random index cases. The transmission probability is 0.12, corresponding to R0 = 1.6. It can be seen that school-age children become ill first, which boosts the overall R0 for »20 days, since the reproductive number for this age group is larger than for all other age groups (see Table 7).





    Supporting Figure 8

    Fig. 8. (a) Effect of seeding rate (number of infecteds per 10,000 daily international passengers at 14 major international airports) and of a static seeding on only day 0 versus a continual seeding every day of the 180-day simulation, on the resulting epidemic curves (for R0 = 1.9). In all simulations, the cumulative attack rate is 43.53%, with the seeding rate only affecting the timing of the epidemic peak. (b) Epidemic curves for various one-time introductions of infecteds on day 0, either of 76 infected people at 14 major airports (the same static seeding simulation shown in the top panel) or of 40 infected people either on the East Coast (New York County) or on the West Coast (Los Angeles County), for pandemic influenza with R0 = 1.9. Also shown for the Los Angeles seeding are three different travel reductions, to either 10% or 1% of the normal long-range travel frequency during the entire 180-day simulation, or to 1% only after the pandemic alert threshold of 10,000 cumulative ill is reached on day 38.





    Supporting Figure 9

    Fig. 9. Spatiotemporal spread of a national epidemic (for R0 = 1.9), starting with 40 infectious people on day 0 in either New York County (left column) or Los Angeles County (right column). Snapshots are shown at day 60, 80, 100, and 120 (from top to bottom), and the corresponding nationally averaged epidemic curves are in Fig. 8.





    Supporting Figure 10

    Fig. 10. (a) Effect of delays in vaccine production and distribution on the cumulative attack rates, 180 days after the initial introduction of pandemic influenza (with R0 = 1.6) into the U.S. A production rate of 10 million doses per week is assumed, ending when a total of 250 million doses have been distributed. A single dose per person is assumed to confer a low efficacy response, and two doses a higher efficacy; for this production rate and limit the vaccination of twice as many people with a lower efficacy is preferred. (b) Effect of delays in implementing a 60% TAP intervention on the resulting cumulative attack rate and number of antiviral courses consumed, 180 days after the initial introduction of pandemic influenza (with R0 = 1.9) into the U.S. Shown is a comparison of a standing TAP policy (in place on day 0) with postalert interventions beginning 1, 4, 7, 10, and 14 days after the pandemic alert threshold 10,000 cumulative ill is reached on day 24. (Solid curves are quadratic polynomial fits to the data points.)





    Supporting Figure 11

    Fig. 11. Epidemic curves for R0 = 1.9 and 2.4, for the baseline scenario without any intervention and with long-distance travel reduced to 10% and 1% of the usual frequency throughout the entire simulation.





    Supporting Movie 1

    Movie 1. Baseline scenario, without any intervention.





    Supporting Movie 2

    Movie 2. Baseline (top) compared to a 60% TAP intervention initiated 7 days after pandemic threshold is reached and continuing until the national supply of 20 million antiviral courses is exhausted. Frames from this movie are shown in Fig. 1.





    Supporting Movie 3

    Movie 3. Baseline (top) compared to a dynamic production and distribution of 10 million doses of a low-efficacy vaccine (single-dose regimen) per week for 25 weeks, beginning such that the first persons treated develop an immune response on the date of the first U.S. introduction.





    Supporting Movie 4

    Movie 4. Baseline (top) compared to a 90% reduction in long-range travel, beginning 1 day after the pandemic threshold is reached and continuing throughout the remainder of the simulation.





PreviousNext
Back to top
Article Alerts
Email Article

Thank you for your interest in spreading the word on PNAS.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Mitigation strategies for pandemic influenza in the United States
(Your Name) has sent you a message from PNAS
(Your Name) thought you would like to see the PNAS web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Mitigation strategies for pandemic influenza in the United States
Timothy C. Germann, Kai Kadau, Ira M. Longini, Catherine A. Macken
Proceedings of the National Academy of Sciences Apr 2006, 103 (15) 5935-5940; DOI: 10.1073/pnas.0601266103

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Mitigation strategies for pandemic influenza in the United States
Timothy C. Germann, Kai Kadau, Ira M. Longini, Catherine A. Macken
Proceedings of the National Academy of Sciences Apr 2006, 103 (15) 5935-5940; DOI: 10.1073/pnas.0601266103
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Mendeley logo Mendeley
Proceedings of the National Academy of Sciences: 103 (15)
Table of Contents

Submit

Sign up for Article Alerts

Jump to section

  • Article
    • Abstract
    • Results and Discussion
    • Conclusions
    • Materials and Methods
    • Acknowledgments
    • Footnotes
    • References
  • Figures & SI
  • Info & Metrics
  • PDF

You May Also be Interested in

Abstract depiction of a guitar and musical note
Science & Culture: At the nexus of music and medicine, some see disease treatments
Although the evidence is still limited, a growing body of research suggests music may have beneficial effects for diseases such as Parkinson’s.
Image credit: Shutterstock/agsandrew.
Scientist looking at an electronic tablet
Opinion: Standardizing gene product nomenclature—a call to action
Biomedical communities and journals need to standardize nomenclature of gene products to enhance accuracy in scientific and public communication.
Image credit: Shutterstock/greenbutterfly.
One red and one yellow modeled protein structures
Journal Club: Study reveals evolutionary origins of fold-switching protein
Shapeshifting designs could have wide-ranging pharmaceutical and biomedical applications in coming years.
Image credit: Acacia Dishman/Medical College of Wisconsin.
White and blue bird
Hazards of ozone pollution to birds
Amanda Rodewald, Ivan Rudik, and Catherine Kling talk about the hazards of ozone pollution to birds.
Listen
Past PodcastsSubscribe
Goats standing in a pin
Transplantation of sperm-producing stem cells
CRISPR-Cas9 gene editing can improve the effectiveness of spermatogonial stem cell transplantation in mice and livestock, a study finds.
Image credit: Jon M. Oatley.

Similar Articles

Site Logo
Powered by HighWire
  • Submit Manuscript
  • Twitter
  • Facebook
  • RSS Feeds
  • Email Alerts

Articles

  • Current Issue
  • Latest Articles
  • Archive

PNAS Portals

  • Anthropology
  • Chemistry
  • Classics
  • Front Matter
  • Physics
  • Sustainability Science
  • Teaching Resources

Information

  • Authors
  • Editorial Board
  • Reviewers
  • Librarians
  • Press
  • Site Map
  • PNAS Updates

Feedback    Privacy/Legal

Copyright © 2021 National Academy of Sciences. Online ISSN 1091-6490